Sign up USA
Proactive Investors - Run By Investors For Investors

Wound Management Technologies gets clearance for its resorbable bone wax

It will be delivered in a unique applicator that allows surgeons to directly apply the waxy product on bleeding bones.
Wound Management Technologies gets clearance for its resorbable bone wax
HemaQuell is a water soluble material used to control bleeding from bone surfaces.

Wound Management Technologies (OTCQB:WNDM) announced its Resorbable Orthopedic Products (ROP) subsidiary has received FDA clearance for HemaQuell resorbable bone wax.

HemaQuell, which is based on a patent acquired in 2009, is a water soluble material used to control bleeding from bone surfaces.

It will be delivered in a unique applicator that allows surgeons to directly apply the waxy product on bleeding bones.

Unlike other non-resorbable "bone wax" the HemaQuell material is completely resorbed (re-absorbed) harmlessly into the body within a week and does not delay healing of bone injury.

Deborah Hutchinson, president of Wound Management Technologies, said: “We are extremely pleased to have this approval for HemaQuell.”

“HemaQuell will generate additional sales opportunities for our company in the operating room,” she added.

View full WNDM profile View Profile

Wound Management Technologies, Inc Timeline

Related Articles

picture of addict
November 15 2017
To build the UK's first £1bn, self-sustainable biotech is the aim for chief executive Clive Dix
scientist looking through microscope
April 11 2018
Kumaraguru Raja sees “multiple catalysts” in the year ahead which could put a rocket under the share price
laboratory
April 12 2018
Mission is to make stem cell treatments accessible and affordable to as many people as possible

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use